Charles E. Geyer, Jr, MD, FACP, on the SOFT Trial
2014 San Antonio Breast Cancer SymposiumCharles E. Geyer, Jr, MD, FACP, of Massey Cancer Center, discusses abstract S3-08, “Randomized comparison of adjuvant tamoxifen plus ovarian function suppression vs tamoxifen in premenopausal women with hormone receptor–positive early breast cancer: Analysis of the SOFT trial,” presented by Prudence Francis, MD.
Related Videos
William M. Sikov, MD, on the CALGB 40603 Trial
William M. Sikov, MD, of Women and Infants Hospital, discusses abstract S4-05, ...
Hope S. Rugo, MD, on the Phase II FIRST Study
Hope S. Rugo, MD, of the University of California, San Francisco, discusses abstract S6-04,
Matthew J. Ellis, MD, on Endocrine Therapy–Resistant Breast Cancer
Matthew J. Ellis, MD, PhD, of the Baylor College of Medicine, offers a brief synopsis of his plenary lecture, "Genome-Directed Therapeutics for Endocrine Therapy–Resistant Estrogen...
Clifford A. Hudis, MD, FACP, on the SOFT Trial
Clifford A. Hudis, MD, FACP, of Memorial Sloan Kettering Cancer Center, discusses findings from abstract S3-08,
Gunter von Minckwitz, MD, of the University of Frankfurt, offers his thoughts on abstract S3-04,
Gunter von Minckwitz, MD, on the Phase III ICE Trial
